Introduction
Schizophrenia (SZ) is a highly heritable yet complex multifactorial psychiatric disorder (Braff, 2015; Braff et al., 2007b; Thibaut, 2006) . Locating genes that are associated with schizophrenia is a key step in identifying potentially remediable biological pathways for the development Schizophrenia Research 174 (2016) [1] [2] [3] [4] [5] [6] [7] [8] [9] of novel treatments. Endophenotypes (e.g., neurocognitive and neurophysiologic measures) reflect components of liability narrower than the broad clinical diagnosis of schizophrenia and may facilitate the search for susceptibility genes and biological pathways to illness (Braff, 2015; Braff et al., 2007b; Braff et al., 2007c; Gottesman and Gould, 2003) . Criteria for endophenotypes include: deficits associated with illness (moderate to large effect sizes between schizophrenia patients and community controls), state independence, heritability, and deficits in unaffected relatives at a higher rate than in the general population (small to moderate effect sizes between biological relatives of schizophrenia patients and community controls; Gur et al., 2007a) . Iacono (1998) suggested an additional criterion for a useful endophenotype is that a deficit be unique to a class of related disorders (i.e., display specificity), but notes that "because psychiatric diagnosis is not perfectly reliable and the validity of the Diagnostic and Statistical Manual (DSM) diagnostic criteria is not firmly established, it is not reasonable to expect a complete absence of the endophenotype in an unrelated disorder that shows appreciable symptom overlap with the target disorder. Also, some endophenotypes will possibly index a dimension or process representing a dysfunction shared across certain disorders." Arfken et al. (2009) and Thibaut et al. (2015) distinguish between endophenotypes and biomarkers of a disease, such that biomarkers are disease specific, can be state-or trait-dependent, and are not necessarily heritable.
Because individual endophenotypes are more proximal functions of gene action than is the diagnostic assignment of schizophrenia itself, and individual endophenotypes are believed to reflect variation among a smaller number of genes than the very large array of genes implicated in schizophrenia, it should be simpler to localize the genetic loci contributing to the endophenotypes than to localize those for schizophrenia (Braff et al., 2007b; Braff et al., 2007c; Gottesman and Gould, 2003 ; Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014). Iacono (1998) suggested that a multivariate phenotype might "have the greatest likelihood of assisting in the search for schizophrenia-related genes." While a number of studies have examined the association between individual endophenotypes and diagnosis, only a few have addressed the additive impact of using multiple endophenotypes simultaneously to improve discrimination between target populations. Comparing univariate and multivariate logistic regression, Price et al. (2006) showed that multivariate logistic regression using four neurophysiological endophenotypes (mismatch negativity, P50 suppression, P300 amplitude, and antisaccade error rate) to differentiate 60 SZ and 44 control subjects produced superior values of sensitivity (82%), specificity (73%), and accuracy (78%) compared to using just one endophenotype. They suggest that this multivariate endophenotype (i.e., the weighted linear combination using the coefficients from the multivariate logistic regression) could be used to increase power in genetic linkage and association analyses. Johannesen et al. (2013) investigated which subset of 14 neurophysiological endophenotypes best separated 50 SZ subjects from 50 healthy normal controls, and how that set of endophenotypes compared to the set that best separated the 50 SZ patients from 50 bipolar patients. The final model for separating SZ subjects from controls included five endophenotypes (P300 amplitude and latency, N100 Target, LFR Target, and GBR Standard), and yielded a sensitivity of 78%, specificity of 80%, and overall accuracy of 79%, but applying this model to distinguish SZ from bipolar patients yielded a sensitivity of 70%, specificity of 58%, and accuracy of 64%. The model that best separated SZ from bipolar patients included three endophenotypes (N100 S1, N100 Target, and GBR Target), and yielded a sensitivity of 74%, specificity of 70%, and overall accuracy of 72%. Peters et al. (2014) investigated the ability of 20 EEG indices to distinguish between 34 SZ and 37 control subjects. They first screened individual endophenotypes by testing for the significance of the area under the curve (AUC; equivalent to performing the nonparametric Mann-Whitney U test; Hanley and McNeil, 1982; Zweig and Campbell, 1993) . Using the 11 indices that were significant, they performed principal components analysis (PCA), resulting in three top factors that explained 77% of the total variance. Using these three factors in a multivariate logistic regression model yielded 82% sensitivity, 70% specificity, and 76% accuracy; however, only one of the factors was a significant predictor in the model.
Numerous candidate endophenotypes for SZ have been proposed, yet there is substantial overlap in endophenotype performance between SZ probands and healthy controls. Furthermore, many endophenotypes may overlap in the information they provide. Identifying a subset of endophenotypes that taken together provide substantial sensitivity and specificity to differentiate between SZ and healthy comparison subjects has a two-fold research utility: practically, the degree to which the test battery can be limited is relevant to study cost, subject burden, and other design considerations, and furthermore, identification of key endophenotypes can help prioritize future genetic studies and improve statistical power by limiting the number of individual endophenotype statistical comparisons. We emphasize that we are not suggesting the use of a subset of endophenotypes to replace clinical diagnosis, nor are we suggesting that endophenotypes that are not part of the identified subset do not matter; rather, we are motivated by design efficiency in order to increase the power of locating those genetic regions associated with schizophrenia that may be the easiest to identify initially.
The goal of the first phase of the Consortium on the Genetics of Schizophrenia (COGS-1) was to investigate the genetic basis of endophenotypes for SZ Gur et al., 2007a) . Results from COGS-1 have been reported by numerous authors Greenwood et al., 2011; Greenwood et al., 2013; Horan et al., 2008; Light et al., 2014; Olincy et al., 2010; Radant et al., 2010; Radant et al., 2007; Radant et al., 2015; Stone et al., 2011; Swerdlow et al., 2007; Turetsky et al., 2007; Turetsky et al., 2008 ) and focus on describing the heritability and deficits in SZ probands of individual endophenotypes. The study described here uses statistical methods to investigate which combination of COGS-1 endophenotypes that we considered best distinguishes between SZ and healthy community comparison subjects (CCS) in a large, well-characterized sample.
Methods

Subjects
The current study utilizes data from the COGS-1 (Braff et al., 2007a; Braff et al., 2007b; Calkins et al., 2007) , a multisite, family-based study on the genetics and heritability of neurocognitive and neurophysiologic SZ endophenotypes. Participants in this study met COGS-1 criteria as SZ probands (n = 345) or CCS (n = 517) and completed at least one endophenotype measure. The SZ subjects completed a structured clinical diagnostic interview (the Diagnostic Interview for Genetic Studies; Nurnberger et al., 1994 ) and a best-estimate consensus diagnostic procedure that included a comprehensive evaluation of psychosis, mood, and substance use disorders and related symptomology Greenwood et al., 2007) . This information was used in concert with a standard medical record review to assess age, smoking status, education level, parental education level, handedness, and age at onset of psychosis; the Family Interview for Genetics Studies (FIGS; Maxwell, 1992) was used to assess subjects' family history of SZ or schizoaffective disorder; and the reading subtest of the Wide Range Achievement Test, 3rd edition (WRAT-3; Jastak and Wilkinson, 1993 ) was used to estimate premorbid intellectual functioning. The SZ subjects were also assessed using the Schedule for the Assessment of Negative Symptoms (SANS; Andreasen, 1983) and Schedule for the Assessment of Positive Symptoms (SAPS; Andreasen, 1984) ; all probands met Diagnostic and Statistics Manual of Mental Disorders, 4th edition (DSM-IV), diagnostic criteria for SZ. Recruitment and ascertainment strategies, in-depth inclusion and exclusion criteria, in-person training and quality assurance guidelines for the assessment team and endophenotype testers, informed consent procedures, and institutional review board approval at all seven study sites are detailed in Calkins et al. (2007) . Inclusion criteria for SZ probands required that both biological parents were available for genotyping, and at least one full sibling unaffected by SZ was available for endophenotyping and genotyping.
Endophenotype assessment battery
The COGS-1 endophenotype assessment battery and its use in the different COGS-1 sub-studies have been discussed in detail elsewhere (see Introduction). We looked at one neurophysiological endophenotype, antisaccade performance (AS; Radant et al., 2007) measured as the ratio of correct antisaccades to total interpretable antisaccades, and 15 neurocognitive endophenotypes: the Degraded Stimulus (DS), 3-digit Identical Pairs (IP), and 4-digit IP versions of the Continuous Performance Test (CPT), which were measured using the signal/noise discrimination index (d′; Gur et al., 2007a) ; the Forward and Reordered condition of the Letter-Number Span (LNS; Horan et al., 2008) measured as the total number of correctly recalled sequences; the California Verbal Learning Test (CVLT; second edition), specifically the total and total semantic clustering scores on trials 1-5 (CVLT total and CVLT semantic; Stone et al., 2011) ; and the sensorimotor speed, motor speed, abstraction and mental flexibility, face memory, spatial memory, spatial ability, working memory, and emotion identification cognitive domains of the Penn Computerized Neurocognitive Battery (CNB; Gur et al., 2007a; Gur et al., 2007b) . For the Penn CNB endophenotypes, all reported scores involving time were multiplied by −1 so that larger scores indicated better performance. Sensorimotor speed and motor speed were reported as z-scores based on the mean and standard deviation for the CCS, and for all other Penn CNB endophenotypes we used the efficiency scores, which were derived by averaging the z-scores for accuracy and speed for that particular measure. All of these endophenotypes were expected to show larger mean values for CCS compared to SZ subjects.
The COGS-1 study also included three other (neurophysiological) endophenotypes: prepulse inhibition (PPI; Swerdlow et al., 2007) and P50 suppression (measured as a ratio and a difference; Olincy et al., 2010) . However, because of the large percentage of missing values for these endophenotypes (34% and 40%, respectively), we did not include them in our analyses.
Data analysis
Demographic differences between SZ and CCS were tested using Student's t-test for continuous variables and the chi-squared test for categorical variables. For categorical variables, confidence intervals for the difference between two proportions were based on inverting the score statistic (Newcombe, 1998) .
As described in Price et al. (2006) and Johannesen et al. (2013) , we first compared unadjusted endophenotypes between groups using summary statistics, strip charts, and two-sample t-tests (effect size was computed using Cohen's d statistic). We also computed distribution by group of the number of endophenotypes in the first quartile (based on combining groups), and the correlations between endophenotypes. Next, we used both logistic regression and random forest models (Breiman, 2001; Kuhn and Johnson, 2013; Liaw and Wiener, 2002) to determine which set of endophenotypes best distinguished between SZ probands and CCS. Following previous COGS-1 studies comparing endophenotype performance in SZ versus CCS, all models included the covariates age, gender, smoking status, site, maximum of parents' education, and WRAT-3 score. The logistic regression and random forest models included only subjects with non-missing values for the model covariates and all 16 endophenotypes.
For logistic regression, the first model included only the covariates, denoted LR 0 EPs. The second model entered each endophenotype by itself (i.e., 16 separate models), denoted LR 1 EP. The third model included all 16 endophenotypes simultaneously as predictor variables, denoted LR 16 EPs. The fourth model, denoted LR Top EPs, used the smallest subset of endophenotypes that were indicated as important based on the results from forward and backward stepwise logistic regression (based on the Bayesian Information Criterion [BIC] ) and random forest [see below]). The association between endophenotype and proband status was summarized with the odds ratios (ORs) for proband, given a decrease (deficit) in endophenotype score equivalent to its interquartile range (Harrell, 2001) . Confidence intervals for the ORs were based on Wald estimates.
Logistic regression models require explicit modeling of nonlinear and interaction terms, and stepwise methods may depend on which criterion is used for inclusion or deletion. Random forest models, however, are nonparametric, inherently account for nonlinearity and interactions, and have built-in cross-validation (Breiman, 2001; Kuhn and Johnson, 2013; Liaw and Wiener, 2002) . We therefore also ran a random forest model using the 16 endophenotypes (denoted RF 16 EPs); variable importance was computed based on the unscaled mean decrease in accuracy (Nicodemus et al., 2010) .
Models were compared using three metrics: generalized R 2 values applicable to logistic regression (roughly the proportion of the variability in the response, i.e., SZ vs CCS, attributable to the estimated model; Harrell, 2001) ; sensitivity, specificity, and accuracy with confidence intervals (sensitivity and specificity presented with joint confidence intervals; Pepe, 2003) ; and Somer's D xy rank correlation (Harrell, 2001) between predicted probabilities and observed responses, which measures how well the model discriminates between SZ and CCS (D xy = 1 denotes perfect discrimination, whereas D xy = 0 implies that the model does no better than a random assignment into groups; D xy is equivalent to the area under the curve: D xy = 2(AUC -0.5)). For the logistic regression models, both the generalized R 2 and Somer's D xy are presented unadjusted, as well as corrected for optimism (i.e., model overfitting; Harrell, 2001 ) based on resampling. ROC curves were calculated to provide a visual comparison of models. Because of the large proportion of subjects with missing values for at least one of the endophenotypes, as a sensitivity analysis we repeated the logistic regressions and random forest using multiple imputations (Buuren and Groothuis-Oudshoorn, 2011) . The imputations were performed using the R package mice (Multiple Imputation by Chained Equations), using predictive mean matching. All 16 endophenotypes and the model covariates were used in the imputations. Fifty imputed datasets were estimated. Pooled summary statistics were obtained by averaging the estimates of models across the 50 imputed datasets. Pooled total variances for summary statistics were estimated using Rubin's formula (3.1.5; Rubin, 1987) .
All analyses were performed using R version 3.2.0 (R Development Core Team, 2011), the EnvStats package (Millard, 2013) to compute summary statistics and plot strip charts, the randomForest package (Liaw and Wiener, 2002) , the rms package (Harrell, 2013) to carry out logistic regressions and compute the R 2 and Somer's D xy values, the pROC package (Robin et al., 2011) to construct the ROC curves, and the mice package (Buuren and Groothuis-Oudshoorn, 2011) to perform the multiple imputations.
Results
Demographic and clinical variables
We obtained data on endophenotypes from 862 subjects: 345 SZ and 517 CCS. SZ probands had an average age of onset of 21 years and were more likely to be male, white, and smokers and to have less education and a lower WRAT-3 score compared to CCS; however, the parents of SZ probands were slightly more educated compared to the parents of CCS (Table 1 ). There were 802 subjects (318 SZ, 484 CCS) with nonmissing data for the model covariates age, gender, smoking status, site, maximum of parents' education, and WRAT-3 score. Supplemental Table S1 presents the demographic and clinical characteristics of the 571 subjects (174 SZ and 397 CCS) with complete data for all 16 endophenotypes and model covariates. Table 2 presents descriptive statistics for the endophenotypes by subject group, as well as the results of two-sample t-tests to compare groups. As expected, all endophenotypes showed larger mean values for CCS compared to SZ subjects. SZ subjects had higher rates of missing values compared to CCS for all endophenotypes. Results based on including only the 571 subjects with complete data for all 16 endophenotypes and adjusting for model covariates were similar (Supplemental Table S2 ), except that DS-CPT was no longer significant. Supplemental Fig. S2 uses strip charts with 95% confidence intervals to illustrate the distributions of endophenotypes by group without adjusting for covariates. The extremely large overlap in performance between groups is evident for all endophenotypes. However, Supplemental Table S3 , which shows the distribution by group of the number of endophenotypes in the first quartile (based on both unadjusted and adjusted scores), indicates that schizophrenia probands are more likely than community control subjects to have lower scores on more endophenotypes. Supplemental Table S4 displays pairwise endophenotype correlations. Emotion identification is relatively highly correlated with all other Penn CNB endophenotypes, except for motor speed (which is only moderately correlated with any of the other Penn CNB endophenotypes). Table 3 displays the results of the logistic regression models used to discriminate between SZ probands and CCS based on various combinations of the 16 endophenotypes. The displayed ORs are based on comparing the odds of declaring a subject a proband assuming the endophenotype is equal to its 25th percentile versus the same odds assuming the endophenotype is equal to its 75th percentile. For example, looking at the results for the antisaccade task using model LR 1 EP, the odds of declaring a subject SZ given a score of 0.64 (the 25th percentile) divided by the same odds given a score of 0.91 (the 75th percentile) was 4.09 with a 95% confidence interval of [2.86, 5.83] . For model LR 16 EPs, in which all 16 endophenotypes were included in the same model, five of the endophenotypes had ORs significantly N1, and two (DS-CPT and spatial ability) unexpectedly had ORs b 1; this result is likely due to collinearity among the endophenotypes, in particular, spatial ability had the highest variable inflation factor (2.4) of the 16 endophenotypes. The forward stepwise regression model included the endophenotypes antisaccade, CPT-IP 3-digit, CVLT total, emotion identification, and motor speed, while the backward stepwise regression model included these same endophenotypes as well as sensorimotor speed and spatial ability. However, the random forest model (model RF 16 EPs; Supplemental Fig. S3 ) clearly indicates that the most important endophenotypes are just the first four (i.e., antisaccade, CPT-IP 3-digit, CVLT total, and emotion identification; model LR Top EPs). There is very little difference in the generalized R 2 or Somer's D xy values between the model that uses all 16 endophenotypes (LR 16 EPs) and the one that uses just the top four (LR Top EPs), and both of these models are superior to using the model that includes just the covariates, model LR 0 EPs, which had R 2 and Somer's D xy values of 0.32 and 0.59, respectively. Supplemental Fig. S4 illustrates Price et al.'s (2006) multivariate endophenotype concept: strip charts by group of the predicted probability of being assigned to the SZ group based on the LR Top EPs model. Table 4 shows the sensitivity, specificity, and accuracy of models LR 16 EPs, LR Top EPs, and RF 16 EPs, and Fig. 1 shows the associated ROC curves. Not surprisingly, the ROC curve and Somer's D xy based on the random forest are lower compared to those based on the logistic regression models because random forest has built-in cross-validation whereas standard logistic regression models do not. Using a predicted probability of 0.5 as the cut-off for declaring a subject to be SZ, the sensitivity is much smaller than the specificity, whereas using a cut-off of 0.3 makes the sensitivity approximately equal to the specificity.
Discriminatory effectiveness of endophenotypes
As a sensitivity analysis, the logistic regression and random forest models were re-estimated based on multiple imputation of missing values using fifty imputations. Supplemental Fig. S5 shows that the ORs and 95% confidence intervals for model LR Top EPs using the original data and based on the multiple imputations are similar. Supplemental Table S5 compares sensitivity, specificity, and accuracy based on the original versus imputed data. Point estimates for specificity and accuracy were similar between the imputation and original analyses. However, point estimates for sensitivity based on the imputation analysis were about 10 and 15 percentage points higher, respectively, for the logistic regression and random forest models compared to the original analysis. This is because for almost all endophenotypes, the mean endophenotype value for the imputed values was less than the mean for the non-missing data, and since more SZ than CCS subjects had missing data, more of the imputed low scoring outcomes were also from the SZ group, increasing the probability that a low scoring subject was from the SZ group.
Discussion
The endophenotype concept is a tool that may potentially identify key genetic loci associated with schizophrenia. However, the enormous overlap in endophenotype performance between schizophrenia and healthy community control subjects displayed in the strip charts shown in Supplemental Fig. S2 emphasizes the complex nature of the disease. We have shown that for the COGS-1 study, using just four endophenotypes (antisaccade, CPT-IP 3-digit, CVLT total, and emotion identification) produces essentially the same discrimination between SZ probands and CCS as using all 16 endophenotypes that we considered. This finding is consistent both between models (logistic regression versus random forest) and datasets (available versus imputed). , and are similar to the estimated heritability of SZ itself of 31% and 44% for nuclear and extended families, respectively, based on the COGS-1 data (Light et al., 2014) . Greenwood et al. (2013) performed a genome-wide linkage analysis on the COGS-1 data, and although the study had limited power, the antisaccade task showed significant genome-wide linkage (LOD of 4 for chromosome 3p14) and emotion recognition almost attained significant genome-wide linkage (LOD of 3.5 for chromosome 1p36). The four key endophenotypes we identified also have the largest effect sizes (Table 2 and Supplemental Table S2 ); however, in general, endophenotypes with smaller effect sizes may end up being identified as important for separating groups using the methods presented here, f After each sequence, the participant is asked to recall the numbers and letters in the same exact order, with no reordering of the stimuli. The number of digits and letters increases by one on each trial, from one up to a maximum length of 8 stimuli. Three sequences of the same length are presented during each trial. The test is discontinued when the subject fails three consecutive sequences of the same length. The score is the total number of correctly recalled sequences. g After each sequence, the participant is asked to repeat the numbers in ascending order first and then the letters in alphabetical order. h Trials 1-5 Free Recall Correct. i Total semantic clustering scores on trials 1-5. j Sensorimotor and motor values were reported as z-scores based on the mean and standard deviation for the community comparison subjects. Z-scores were based on values that had been multiplied by −1, so that a larger value indicated a better performance. k Efficiency scores were derived by averaging the z-scores (based on the mean and standard deviation for the community comparison subjects) for accuracy and speed.
because a variable can become important once other variables are in the model (Sun et al., 1996) . Identifying a subset of endophenotypes with good discriminatory characteristics can help prioritize future endophenotypic and genetic studies in schizophrenia. Limiting the test battery will reduce cost and subject burden, and limiting the number of individual endophenotype comparisons can increase statistical power. Studies that enrich the sample by choosing controls that perform well on all or most endophenotypes and/or probands that perform poorly on all or most endophenotypes (Supplemental Table S3b ) will be easier to conduct, and genetic analyses could involve the multivariate endophenotype (Supplemental Fig. S4 ).
Our study is similar to that of Price et al. (2006) and Johannesen et al. (2013) except that we used a random forest model in addition to logistic regression models, and our results are based on one of the largest study samples to date that underwent uniform endophenotypic assessments. Our results for sensitivity (85%) and specificity (85%) based on the logistic regression model using just the four endophenotypes (model LR Top EPs) and a cut-off of 0.3 for classification are superior to those of Price et al. (2006) , Johannesen et al. (2013) , and Peters et al. (2014) . However, more realistic estimates for future studies based on the random forest model indicate a sensitivity of 81% and specificity of 74%, which are similar to those of the three previous studies.
Some limitations of the previous studies should be discussed. First, in addition to sensitivity, specificity, and accuracy, Price et al. (2006) present estimates of positive predictive value (PPV) and negative predictive value (NPV); however, correct estimates of PPV and NPV require knowing the prevalence of the disease and therefore require using a cohort (not case-control) design or else an external estimate of the prevalence in the computation of the estimates (Pepe, 2003; Pepe et al., 2004; Zweig and Campbell, 1993) . Second, given that the focus of these studies was on using logistic regression models, there is no constraint on the distribution of the predictor variables (i.e., the endophenotypes), yet Johannesen et al. (2013) removed "outliers" based on looking at boxplots. Third, Peters et al. (2014) selected variables for inclusion by using results from univariate tests, which is not an optimal method to determine the most important variables for a multivariate model, because a variable by itself may not significantly distinguish between groups but can become significant once other variables are in the model (Sun et al., 1996) . Fourth, it is not clear whether Peters et al. (2014) performed PCA on the raw data or the normalized (i.e., ztransformed) data. If the variables are measured on scales with widely different ranges, then the results of the PCA based on the raw data will be dominated by the variables with the largest range (Johnson and Wichern, 2007) .
Supplemental Table S3 shows that the four endophenotypes we identified are moderately correlated with each other (r = 0.35 to 0.45), except for the correlation between antisaccade and emotion identification (r = 0.28). However, these endophenotypes are associated with diverse neurological functions: the antisaccade task measures the ability of the oculomotor system to inhibit prepotent responses , the Continuous Performance Test-Identical Pairs 
Table 4
Sensitivity, specificity, and accuracy with 95% confidence intervals for logistic regression and random forest models for subjects with non-missing values for all 16 endophenotypes (n = 571).
Classify as proband when model probability N 0.5 Classify as proband when model probability N 0. numbers version measures sustained focused attention with a demand on working memory (Cornblatt and Keilp, 1994) , the California Verbal Learning Test measures verbal declarative memory , and the Penn CNB emotion identification task measures social cognition . Using 12 of the 16 COGS-1 endophenotypes presented here (CPT-IP 3-digit, CVLT semantic, LNS forward, and Penn CNB working memory were omitted), as well as PPI, P50 gating, and an additional DS-CPT measure (reaction time for targets), Seidman et al. (2015) used factor analysis applied to SZ probands (n = 83), CCS (n = 209), and SZ nonpsychotic siblings (n = 151) with non-missing values for all 15 endophenotypes to identify five factors, and then looked at endophenotype loading on each factor, the correlation between factors, and the heritability of the factors. Ten of the 15 endophenotypes were associated with at least one of the factors, and the factor structure was similar within each diagnostic subgroup. Based on the loadings, the five factors were identified as reflecting primarily episodic memory, working memory, perceptual vigilance, visual abstraction, and inhibitory processing, respectively, with heritabilities ranging from 22% to 39%. Unlike our study, which focuses on which subset of endophenotypes best distinguishes SZ probands from CCS, the study by Seidman et al. (2015) sought to identify underlying constructs (factors) that are responsible for the correlations between endophenotypes (Johnson and Wichern, 2007) . The four endophenotypes identified in our study load on Seidman et al.'s episodic memory (antisaccade, CVLT total, and emotion recognition), working memory (CVLT total), and inhibitory process (antisaccade) factors (Seidman et al. did not include CPT-IP 3-digit, but CPT-IP 4-digit loads on working memory).
There are many strengths to our study. The data are based on one of the largest study samples to date that has undergone uniform endophenotypic assessments. Unlike past studies investigating multivariate endophenotypes that used only neurophysiological endophenotypes, we used both neurophysiological and neurocognitive endophenotypes. We used multiple methods to determine which subset of endophenotypes best distinguishes diagnostic groups, including forward stepwise regression, backward stepwise regression, and random forest. Finally, we used multiple imputations to show that our results are essentially the same after imputing missing values.
There are also limitations to our study. The number of neurophysiological endophenotypes available was limited compared to past studies. (Neurophysiological endophenotype collection in a substantially larger cohort of SZ cases and healthy comparison subjects from our COGS-2 study has been reported , and genetic analyses are forthcoming.) We also did not have equivalent measurements in related diagnostic groups (e.g., bipolar disorder), which would be necessary to examine whether the combination of endophenotypes identified in this study will also show good discrimination between SZ and other psychiatric diagnostic groups. Finally, the COGS-1 inclusion requirement that both biological parents be available for genotyping, and at least one full sibling unaffected by SZ be available for endophenotyping and genotyping, may limit the generalizability of our results.
In conclusion, our study confirms past studies that showed that using a multivariate approach to endophenotype-based indices for discriminating SZ probands from healthy controls yields sensitivity and specificity on the order of 80% using just a few endophenotypes, and in our study, four endophenotypes produced essentially the same discrimination between groups as using all 16 endophenotypes. These findings, and applying the methods we used here to other datasets that may include endophenotypes we did not look at here, can help direct future studies by helping researchers decide which endophenotypes to include in a test battery and improving statistical power by limiting the number of individual endophenotype statistical comparisons.
Supplementary data to this article can be found online at http://dx. doi.org/10.1016/j.schres.2016.04.011.
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